Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Julyan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Hearing Research|June 15, 2005
Auditory cortical activation and speech perception in cochlear implant users: effects of implant experience and duration of deafnessKevin M J Green, Peter J Julyan, David L Hastings, et al.
Cochlear Implants International|October 11, 2008
Neural plasticity in blind cochlear implant usersKevin M J Green, Richard T Ramsden, Peter J Julyan, et al.
European Journal of Radiology|April 13, 2013
Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patientsThomas D Westwood, Celia Hogan, Peter J Julyan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Optimization of the injected activity in dynamic 3D PET: a generalized approach using patient-specific NECs as demonstrated by a series of 15O-H2O scansMatthew D Walker, Julian C Matthews, Marie-Claude Asselin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicinLeonard W Seymour, David R Ferry, David Anderson, et al.
IEEE Transactions on Medical Imaging|June 14, 2012
Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapyTony Shepherd, Mika Teras, Reinhard R Beichel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumorsSaifee A Mullamitha, Nhuan C Ton, Geoff J M Parker, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Hearing Research|June 15, 2005
Auditory cortical activation and speech perception in cochlear implant users: effects of implant experience and duration of deafnessKevin M J Green, Peter J Julyan, David L Hastings, et al.
Cochlear Implants International|October 11, 2008
Neural plasticity in blind cochlear implant usersKevin M J Green, Richard T Ramsden, Peter J Julyan, et al.
European Journal of Radiology|April 13, 2013
Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patientsThomas D Westwood, Celia Hogan, Peter J Julyan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2009
Optimization of the injected activity in dynamic 3D PET: a generalized approach using patient-specific NECs as demonstrated by a series of 15O-H2O scansMatthew D Walker, Julian C Matthews, Marie-Claude Asselin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicinLeonard W Seymour, David R Ferry, David Anderson, et al.
IEEE Transactions on Medical Imaging|June 14, 2012
Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapyTony Shepherd, Mika Teras, Reinhard R Beichel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumorsSaifee A Mullamitha, Nhuan C Ton, Geoff J M Parker, et al.
Pageof 1